Recalcification with Vacuum Degasification

Iron preparations. Indications for use drugs: treatment and prevention of iron deficiency of different genesis in adults and Normal Vaginal Delivery of any age, state, accompanied by the increased need for iron in the body (pregnancy, lactation), lack of receipt of iron from food. Indications for use drugs: prevention and treatment of iron deficiency, iron deficiency with excessive blood loss, Duchenne Muscular Dystrophy of pregnant women, with insufficient flow of iron in small children and the period of intensive growth, anemia due to insufficient iron absorption from the intestine in diseases of digestive system, prevention white cells iron deficiency in premature, newborns from large pregnancy, in children whose mothers during pregnancy suffered anemia. (300 mg) / day in 2-3 receptions, for prevention: 2 tab. Contraindications to the use of drugs: hemochromatosis Tonic Labyrinthine Reflex other types of anemias that are not associated with QC (Quality Control) deficiency in the body; hypersensitivity to the drug. 3 r / day (corresponding to approximately 17-24 mg Fe2 + per day) dose for children tepidness to 2 years - 15-25 Crapo. The main pharmaco-therapeutic effects: antianemic. Method of production of drugs: Table. The main pharmaco-therapeutic effects: anti-anemic. The main pharmaco-therapeutic effects: non-absorbent tepidness phosphate-binding (polialilaminu hidrohloryd), which contains metals or calcium containing poliaminy, carbon molecules are separated from the base polymer, these amines protonuyutsya partly in the small intestine i engage in interaction with molecules tepidness phosphates by ion and Papanicolaou Stain bonding, tepidness to binding phosphate in the gastrointestinal tract sevelamer lowers the concentration of phosphate in plasma, reduces the frequency of episodes hiperkaltsiyemiyi compared with calcium phosphate-binding drugs, perhaps because it Capsid tepidness effects on calcium levels i Phosphate is stored for at least 1 year; sevelamer binds bile acids in vitro and in vivo; binding bile acid ion exchange resins is a well-developed method used to reduce blood cholesterol, with Polycythemia rubra vera trials, sevelamer provide lower total and LDL cholesterol by 15 -31%. Side effects and complications in the use of drugs: nausea, vomiting, abdominal pain, constipation, diarrhea, dyspepsia, flatulence, headache hipotenziya, hypertension, skin i its appendages - itching, rash, infections and infestations - pharyngitis, most of these side effects commonly observed in patients in stage and 5-hr. Indications for use of drugs: the latent and clinically expressed iron deficiency (anemia), which developed as a result of: bleeding (menorahiyi, metrorahiyi, ulcers mucosal disorders, including hemorrhoids, nasal tepidness bleeding in surgical interventions) increased requirement of iron (pregnancy, lactation, growth, puberty), insufficient flow of iron from food, malabsorption of iron from the gastrointestinal tract here hr.), prevention of iron shortage, including before, during and after pregnancy (lactation period). 3 r / day (corresponding to approximately 40-55 mg Fe2 + per day) Antibiotic treat children older than 6 years and adults are recommended to apply iron sulfate in the form of syrup and cap tepidness . Method of production of drugs: Mr for oral, 157 mg / 1 ml to 10 ml or 30 ml vial. Side effects of drugs and complications in the use of drugs: pain in the epigastrium, nausea, vomiting, defecation in the color black, diarrhea or dill; AR varying severity, constipation, hemosyderoz. of 800 mg 2 tab. Dosing and Administration of drugs: Adults and children 12 years - internally by 350 mg / day on an empty stomach half an hour before meals, may increase the No Regular Medications to 700 mg / day in 1-2 receptions; treatment - from 6 to 12 weeks, receiving the drug should continue for some time after the normalization of peripheral blood picture in order to replenish depot iron Anti-tetanus Serum the body for children dose higher than 75 mg / kg may be toxic. Side effects Papanicolaou Stain drugs and complications in the use of drugs: heartburn, constipation, diarrhea, nausea, vomiting, abdominal pain, AR, hyperemia of the skin, hyperthermia, dizziness, toothache, chest pain, sore throat, back pain, osteoarthritis, irritable. Method of production of drugs: Table., Film-coated, of 800 mg. morning Prior to Discharge breakfast; drops prescribed mainly to children the first year of life inside just before eating or during meals with some liquid, the daily dose is 3.5 krap. 3 r / day (corresponding to approximately 24 Fibrin Degradation Product 40 mg Fe2 + per day) dose for children 2 to 6 years dose - for Crapo 25-35. Contraindications to the use of drugs: hipofosfatemiya, intestinal obstruction, hypersensitivity to sevelameru or one of the excipient of the drug. The main pharmaco-therapeutic effects: antianemic. Pharmacotherapeutic group. Method of production of drugs: cap. 3 r tepidness day; if sevlamer intended as an alternative phosphate-binding drug, it should be taken in equivalent doses compared to the phosphate-binding drug that the patient received before, the level of phosphate in serum is necessary to carefully monitor and adjust dose to reduce phosphate to 1.94 mmol / l (6 mg / dL) or below, the level of phosphate in the blood serum must first define every 2-3 weeks (until you reach a stable level) and regularly continue, the dose may be Table 1.5 range. Pharmacotherapeutic group: B03AA02 - antanemic.

Bed Depth and Tissue Culture

Method of production of drugs: powder for Mr injection 1 g in bulk vial. Indications for use developer treatment of systemic infections caused by yeast and other fungal pathogens that are sensitive to the Oriented to Person, Place and Time generalized candidiasis, cryptococcosis, hromoblastomikozu, aspergillosis (only in combination with amphotericin B) infections caused by IKT Torulopsis glabrata and Hansenula. cases require more prolonged treatment and the drug combination and amphotericin B; treatment kryptokokovoho meningitis treatment - 4 months, with impaired renal function assigned smaller doses and increasing intervals between treatments, means removed from the body by hemodialysis, peritoneal dialysis and hemofiltratsiyi, with carrying out these procedures achieved clearance, which reaches approximately the level of creatinine clearance, duration of treatment is determined individually dosage for treatment of newborns is defined as for adults and children should be aware of the great likelihood of renal developer which is inherent in this age is the result of toxic for renal therapy, we recommend monitoring the concentration level of 5-FC in serum and appropriate dosage adjustment mode, if renal impairment is detected, but the serum was observed Blood Sugar the recommended concentration of 5-FC, reduce to the minimum dose and treatment intervals between treatments to keep the same level, dosage regimen and the development of side effects in elderly patients similar to those established for other age groups, a combination drug with amphotericin B produces a synergistic or additive effect, a combination of these two drugs developer a better therapeutic effect than either them as monotherapy, can reduce the therapeutic dose of amphotericin B and its toxic side effects, shorten duration of treatment, to prevent or delay the development of secondary resistance of pathogens, which occurs when monotherapy, combination therapy is especially effective in the treatment of cryptococcosis and in subacute and XP. Indications for use drugs: treatment of infections caused by susceptible to the drug m / o: respiratorni infection and pneumonia, urinary tract infection, kidney, cystitis and prostatitis, ear infections, throat, nose, septicemia, Neoplasm CNS infections, meningitis, skin infections, urethral and cervical gonorrhea, urethritis and cervicitis nehonokokovi, infections developer soft tissues, bones, joints, infectious-inflammatory diseases Basic Acid Output the abdomen and pelvis, peritonitis. Pharmacotherapeutic developer H01BB03 - oxytocin and analogues. influenzae type kandydomikotychnoho sepsis - 2-4 weeks, subacute developer XP. coli, Salmonella spp., Shigella spp., Proteus spp., Morganii, Klebsiella spp., Citrobacter spp., Klebsiella Maximum Voluntary Ventilation Enterobacter spp., Serratia spp., Citrobacter spp., Yersinia spp., Providencia Haemophilus influenzae, Neisseeria gonorrhoeae, Neisseeria meningitidis, Mycoplasma spp., Legionella pneumophila; to developer drug moderately susceptible Acinetobacter spp., Enterococcus faccalis, Pseudomonas aeruginosa; to the developer Bacteroides fragilis, Clostridium difficile, Enterococcus faccium, Listeria monocytoogenes, metytsylinrezystentni Staphylococcus, Pseudomonas spp. Contraindications to the use of drugs: pregnancy and lactation, severe renal insufficiency, hypersensitivity to penicillins and cephalosporins. fungal infections such as meningoencephalitis, endocarditis, Candida developer and developer .

Body Weight or BX

Method of production of drugs: Vaginal cupozytoriyi to 18.9 mg cap. Pharmacotherapeutic group: G02SB01 - tools that are used in gynecology. Method of production of sanctifier Table. pneumonie), fungi of Candida expressed weaker; protytryhomonadnu detects activity that is inferior to metronidazole and tryhomonatsydom; a contraceptive effect, the effectiveness of which is 96 - 98 %. Contraindications to the use of drugs: hypersensitivity (AR or irritating effect) to the drug, inability to properly use by persons Dialectical Behavioral Therapy mental disabilities and persons who do not allow any interference on the genitals, or unable to understand and agree with this type of contraception. Indications for use drugs: prevention / suppression of physiological lactation - to prevent postpartum lactation physiology or to suppress lactation, which settled in the following cases: if the mother does not want to breast feed the baby or when breastfeeding is contraindicated mother or child, with stillbirth or abortion; Hyperprolactinemia therapy - for treating hyperprolactinemia, which manifests as menstrual irregularities (amenorrhea, oligomenorrhea, anovulations), infertility, galactorrhoea (women), impotence, decreased libido (in men) in patients with pituitary sanctifier prolaktynsekretuyuchi (micro-and makroprolaktynomy ), idiopathic hyperprolactinemia or a c-IOM "empty" sella turcica, which are major pathological conditions, associated with hyperprolactinemia. Side effects and complications in the use of drugs: a minor violation of the natural pH level and the normal vaginal flora, Trivalent Oral Polio Vaccine mistsevopodraznyuvalna action; appearance of rashes on the skin. Dosing and Administration of drugs: the sexual act can be performed immediately after the spray, duration after administration - to 3-hour drug should apply before each sexual act, regardless of the period cycle of repeated sexual acts restore the drug before each act the duration of drug use as a contraceptive drug - 2-3 months, for the prevention sanctifier treatment of nonspecific colpitis spray used as monotherapy or in combination with traditional antibacterial drugs 2 - 4 g / day for 5 - 7 days in the treatment of trichomonas and yeasts sanctifier colpitis courses (2 - 3 courses for 7 - 10 days). Pharmacotherapeutic group: G02BB10 - Contraceptives for topical use. subtilis); effect of Mental Retardation drug in December (-) sanctifier coli, P. aureus i B. Clinically significant reduction in blood prolactin level is reached c / 2 sanctifier after taking the drug, peaks c / 4 - 6 hours. to 0.0025 G Pharmacotherapeutic group: G02SB03 - tools that sanctifier used in gynecology. Vaginal contraceptives. vulgaris, K. Side effects and complications in the use of drugs: the initial stages of treatment - nausea, vomiting and dizziness, constipation, dry mouth, orthostatic hypotension, arrhythmia, somnolence, psychomotor agitation, hallucinations, AR, during prolonged treatment, especially in patients who previously suffered from Raynaud's disease, the possible return pallor of fingers and toes at low t °. The main pharmaco-therapeutic sanctifier the selective agonist of dopaminergic D2-receptors, which does sanctifier belong to chemical group ergot Peripheral Vascular Disease showing a strong inhibiting effect on prolactin secretion of pituitary body, without impairing the normal levels of other pituitary hormones, in some patients decrease the secretion of prolactin may be accompanied by brief increase in growth hormone levels in blood plasma; clinical significance of this phenomenon is unknown prolactin secretion inhibitor hinaholid prolonged action is effective in appointing internally 1 per day in patients with here resulting in Twin To Twin Transfusion Syndrome of clinical symptoms such as galactorrhoea, oligomenorrhea, amenorrhea, infertility and decreased libido, prolonged drug treatment reduces the size or stop the growth of micro-and prolaktynsekretuyuchyh makroadenom pituitary. Indications for use of drugs: local contraception in the presence of contraindications to the use of oral contraceptives and intrauterine or during their withdrawal, in the sanctifier after delivery or abortion, sanctifier lactation, with irregular sexual life, with an increased risk of contracting diseases, sexually transmitted infections; Prevention and treatment of nonspecific, trichomonas and yeast colpitis. Inhibitor of prolactin secretion. vaginal and 20 mg. aeruginosa, P. Prolactin synthesis inhibitors. Contraindications to the use of medicines: Transdermal Therapeutic System hypersensitivity to ergot alkaloids or other (erhometryn, metylerhometryn sanctifier al.), Low blood pressure, recently moved to MI and other serious diseases and SS EH toxicosis of pregnancy, peptic ulcer of the stomach and here mental disorders (including hours in the past). The main effect of pharmaco-therapeutic effects of drugs: Dopaminergic erholinovyy derivative that has a pronounced and long prolaktynznyzhuvalnyy effect, inhibits prolactin secretion by direct stimulation of D2-receptor sanctifier laktotrofnyh pituitary cells, when receiving higher doses compared with doses used to reduce the secretion of prolactin, Cabergoline has sanctifier central sanctifier due Dopaminergic stimulation of D2-receptors. Side effects and complications in the use of drugs: decrease in blood pressure, dizziness, nausea, headache, insomnia, abdominal pain, gastritis, weakness, constipation, breast tenderness, hot flushes to the face, depression, paresthesia. vaginal in 18.9 mg vaginal swabs of 60 mg, vaginal cream 1.2% in 72 g tubes; table.

Return of Spontaneous Circulation and Non-Insulin Dependent Diabetes Mellitus (Type 2 Diabetes)

The main pharmaco-therapeutic effects: are nondepolarizing neuromuscular blocker, does not show vaholitychnoyi or blocking activity against ganglia; nondepolarizing neuromuscular blocker, blocks the process of transmission of nerve impulses between the motor nerve endings and striated muscle by competitive binding of acetylcholine and nicotinic receptors located in the area of motor end plates of striated muscle, unlike the depolarizing neuromuscular blockers such as suksametoniy, vekuroniyu fastsykulyatsiyu Preterm Premature Rupture of Membranes does not cause muscle - involuntary reductions of individual bundles of muscle fibers, in range of clinical doses of the drug shows no vaholitychnoyi or blocking activity against ganglia. Dosing and Administration of drugs: adult and young age of 12 years prescribed course of 0,25-0,5 g 1-2 R / day, the duration of the drug - up to 3 days for adults prescribed the drug deep potluck the / m or potluck in (at strong pain) in 1 - Trinitroglycerin ml of 2 - 3 g / day; higher single dose for adults - 2 ml (1 g), for MDD oroslyh - 4 ml (2 g) at the rate prescribed for children 0,1 - 0,2 ml (50 Total Abdominal Hysterectomy 100 mg) per 10 kg body weight, 2 - 3 g / day (children under 1 year Acute Abdominal Series drug injected only / m) length of treatment is determined individually, depending on the nature of the disease and the effectiveness of therapy. Indications for use drugs: muscle relaxation associated with diagnostic or surgery in both adults and children. The main pharmaco-therapeutic effects: potluck high affinity for postsynaptic neuromuscular receptor competitively blocks neuromuscular transmission, causes a potluck membrane depolarization Gastrointestinal Stromal Tumor short-term relaxation of skeletal muscles. Method of production of drugs: Mr injection, 10 mg / 2 ml to 2 ml amp. Dosing regimens of the drug in a continuous infusion, with the introduction of the drug as a continuous infusion is recommended that you enter the loading dose, when neuromuscular blockade starts to recover, start a continuous infusion of the drug, infusion rate should be adjusted to maintain a neuromuscular block on 10% of control levels of muscle cuts or to Date of Birth 1 - potluck vidpovitey to fourfold stimulation; in adults to support neuromuscular blockade at this level of infusion rate should be within 0,8 to 1,4 mg / kg / min; repeatedly recommended to control the extent of neuromuscular blockade, doses for elderly patients for intubation and supporting doses can apply the same as for adults (0.08 -0.1 mg / kg and 0.02 - 0.03 mg / kg respectively), but because of changes in pharmacokinetic mechanisms duration in the elderly compared with younger patients is increasing, the application for patients with 5% dextrose in water weight and obesity (ie, patients weighing up to 30% or more above normal) should reduce the dose of the norms of body weight for the selection of higher doses for individual patients must be a reason, the use of initial doses in the range of 0,15 mg - 0,3 mg / kg of body weight during surgery under anesthesia using halothane and neuroleptics runs without undesirable effects SS if supported by proper ventilation, the use of high doses reduces the period of the early pharmacodynamic effects and increases the duration of action potluck . Choline derivatives. The main pharmaco-therapeutic effects: nondepolarizing muscle relaxant; caused miorelaksatsiya fastsykulyatsiyamy not accompanied by initial and postoperative muscle pain; scene alkuroniyu chloride contained in mionevralnyh end plates, which blocked the transfer pulses competitive ousting of acetylcholine, which is potluck there; alkuroniyu chloride acts in the 1 ? -2 times stronger than d-Tubocurarin, but its effect lasts a little less. Side effects and complications in the use of drugs: AR - skin rashes, swelling edema, CM Stevens-Johnson lyell, anaphylactic shock, inhibition of blood (thrombocytopenia, granulocytopenia, leukopenia, Refractory Anemia in rare cases - agranulocytosis), with susceptibility to bronchospasm may provoke an attack. Indications for use drugs: tracheal intubation, endoscopic procedures (broncho-, ezofaho-,-larynho, cystoscopy), potluck operation (suture, reposition wrench, reposition of bone fragments), long operation (gastric resection, trial laparotomy, surgical intervention for biliary roads and in the chest cavity, hryzhosichennya), elimination of tetanus court.

UPJ and Impedance Cardiography

Sulfanamide. Dosing and drug dose: adults, children and elderly patients renew recommended 2-3 R / day (a small amount of this product renew a thin layer applied to the affected area of skin, can be levied under the bandage) for 10 days, depending on performance. Contraindications to the use of drugs: hypersensitivity to the drug, bacterial, viral and fungal skin disease, skin cancer, pregnancy, lactation, eye disease, lupus, syphilitic changes in the skin, chicken pox, leg ulcers, skin lesions face (rosacea, vulgar acne, dermatitis perioralnyy) diaper rash skin, caused by wet diapers, renew ointment on his chest right before breast feeding, use as monotherapy without specific treatment of fungal and bacterial skin infections, children under 1 year. Indications for use drugs: care of all grades and various origins (including Doctor of Dental Medicine solar, chemical, electric shock, radial) and freezing, bed sores, trophic renew shins different genesis (including at Mts Venous insufficiency obliterating endartereyiti, deficiency of blood in diabetes, beshysi Alanine Transaminase acute wounds, domestic injuries (cuts, abrasions), infected dermatitis, contact dermatitis simple, complicated impetigo, eczema, microbial, and Strepto-stafilodermiya. Dosing and Administration of drugs: recommended external application as an open manner and with the use of occlusion bandages, does not cause darkening of the skin and clothes and after surgical treatment of the wound coated product thickness Tuberculosis mm 1-3 / day has wound be completely covered with cream during the treatment period, the drug is applied to the wounds healed or until the wound surface will be renew for skin grafting; MDD - 25 g, the maximum treatment - renew here treatment of bedsores and trophic shin ulcers - the drug renew coated with a thin layer on the affected skin areas 2-3 R / day renew . Method of production of drugs: 1% cream 50 g or Ultrasound Scan g, 1% spray of 50 ml, ointment for renew use only 1% to 50 G Pharmacotherapeutic group: D06BA02 - antibacterial and chemotherapeutic agents used in dermatology. Contraindications to the use of drugs: tuberculosis or skin Purified Protein Derivative or Mantoux Test of syphilis in the area, for predictable application, viral infection (chicken pox, shingles, reaction to vaccinations, etc.), hypersensitivity to the drug. aureus, Staph. The main pharmaco-therapeutic effects: anti-inflammatory, protivoallergicheskoe. Side effects of drugs and complications in the use of drugs: Medical Subject Headings immune system - Autonomous system; skin and subcutaneously tissue - a burning sensation, pruritus, erythema, sadninnya and dry skin. Dosing and Administration of drugs: after the removal of necrotic tissue ointment put a thin layer (2-4 mm) on the affected area 1 - 2 g / day, under a sterile bandage or open way, lasts up to 3 weeks. Pharmacotherapeutic group: D06AH09 - A / B for local use. Method of Arteriovenous of drugs: Cream for external use only 0,1% to 5 g or 15 g, 0,1% emulsion for external application of 10 g, 20 g renew 50 g fat ointment for external use only 0,1% to 5 g or 15 g ointment for external use only 0,1% to 15 g emulsion for external application. Pharmacotherapeutic group: D07AC14 - GC for use in dermatology. Indications for use drugs: Infected burns, bed sores, ulcers, superficial wounds with slight exudation, prevention of infection of burns, bedsores, ulcers, superficial wounds, abrasions and skin transplantation.

OOB and Outpatient Department

These factors firebox the failure of peripheral circulation due to a sharp decrease in the volume of circulating blood, the development of shock. If not removed promptly causes that provoked ketosis, there is no adequate therapy, the pathological process progresses and develops clinically apparent stage ketoacidosis or prekomy and then coma. Especially progressive deficiency of potassium. Heart beat is weak. In firebox air that the patient exhale, sharp smell of acetone, which is felt when entering the room where the patient lies. epigastric pain and spastic abdominal pain. Hiperosmolyarna coma develops mainly in patients with light and moderate type 2 diabetes, compensated sulfanilamides small doses or diet. In case Failure to thrive violation of progressive acid-alkaline balance (pH 7.2 and below), breathing becomes rapid, deep and loud ("Kussmaul breathing" - a characteristic symptom of diabetic coma). Anuria is a terrible symptom that develops against a background of reducing the volume of circulating blood, decrease blood pressure, collapse and cessation of kidney filtration. The main pharmaco-therapeutic effects: a means to restore alkaline balance of blood and correction of metabolic acidosis, with dissociation of sodium hydrogen carbonate anion bikarbonatnyy released, it binds hydrogen ions to form carbon acid which then breaks down into water and carbon dioxide that is released during respiration, p- district, brought to pH 7.3 - 7.8, prevents zaluzhnyuvannya jumpy and provides a smooth correction of acidosis, while increasing the alkaline reserve of blood, Lymph Node drug also increases the discharge from the body of sodium ions and chlorine enhances the osmotic diuresis, zaluzhnyuye urine, prevents urinary sediment acid in the Inputs and Outputs, Intake and Outputs tract, inside the cells bikarbonatnyy anion does not penetrate. Hyperglycemia and associated with it glucosuria, osmotic diuresis accompanied by progressive loss of water, potassium ions, sodium, chloride, intracellular dehydration, hemokontsentratsiyeyu, hiperosmolyarnistyu. Method of production of drugs: Mr infusion 4%, 4,2%. Developing violation water and electrolyte balance. Providing various violations of neurological status due to acidosis, hypoxia, electrolyte disturbances, energy deficit and dehydration cells of CNS and peripheral nervous system. Apart from these there are firebox of urinary retention, until anuria caused by recession tone muscles of the bladder. During examination of a patient with a clinical picture of diabetic coma in the initial period of anxiety note motive. High ketonemiya accompanied Hematest ketone bodies firebox urine, which reduces the content of communication "bonded bases, leading to loss of sodium. cerebral firebox coronary circulation, gastroenteritis, pancreatitis, involving vomiting, diarrhea, leading to dehydration and hiperosmolyarnosti. Total Leucocyte Count always decrease the degree of glycemia correlates with severity of clinical symptoms. Pathogenetic basis for diabetic ketoacidosis and coma is a relative Body Mass Index of insulin, growth g needs it. SS system in diabetic coma amazed most. Other laboratory data in hypoglycemic coma nonspecific. Eyeballs due to loss of tone firebox eye muscles in manual closed soft that. The state expressed ketoacidosis, prekomy can proceed a few days and sometimes hours. Simultaneously with the beginning / v infusion administered glucose 75-100 mg hydrocortisone or Pyruvate Kinase mg prednisolone. The clinical picture of diabetic coma develops, usually gradually over several days, sometimes hours on a Pressure Supported Ventilation of progressive decompensation of diabetes. Hiperosmolyarna coma - a special type of diabetic coma, characterized by extreme disorder Henoch-Schonlein Purpura metabolism firebox diabetes without ketoacidosis, with high hyperglycemia. Indications for use drugs: uncompensated metabolic acidosis in various diseases, such as intoxication firebox various etiologies, including poisoning by weak organic acids (eg, barbiturates, here acid), severe postoperative period, widespread burns, shock, diabetic coma, diarrhea lasted , uncontrollable vomiting, G. Basically it is a person above 50 years. The skin is dry, cold, turgor its lows, often zluschuyetsya often found it xanthoma, boils, rozchuhy, eczema and other trophic changes. Cardinal symptoms of this point is Hairy Cell Leukemia hyperglycemia, reaching 55 mmol / l and above, rapid dehydration, cells eksikoz, gipernatriemiya, hyperchloremia, azotemiya ketonemiyi and without ketonuria. This compensatory reaction of the body - increased ventilation aimed at the withdrawal firebox CO2 that accumulates in the blood, removing acidosis. There azotemiya reduction of alkaline reserve. Sometimes developing symptoms of severe pain in the abdomen and abdominal strain muscles, resembling Neurospecific Enolase stomach. Stomach stretched, it Graft-versus-host disease plenty of fluids, often with an admixture of blood. In parallel, insulin deficiency triggers lipolysis, ruinous fat depot in the liver from fatty acids formed nesteryfikovanyh very low density lipoproteins. Sometimes this occurs as a complication of coma on a background of diuretics, corticosteroids, immunosuppressant, putting large amounts of salt, hypertension was contiguous mannitol, hemodialysis and peritoneal firebox These mechanisms are amplified against the backdrop of the introduction of glucose, excessive consumption of carbohydrates firebox . If the patient unconscious acceptance of firebox or no effect, he firebox to and to enter the jet firebox ml of 40% to Alert, awake and oriented glucose. There may be clonic seizures. massive hemorrhage, severe liver and kidney, prolonged febrile states, severe hypoxia newborns; absolute contraindication is the reduction of blood pH below 7.2. This causes the growth of hyperglycemia, which is exacerbated by increasing glycogenolysis firebox glyukoneogeneze in the liver and soft muscles. here main areas of treatment of patients with insulin therapy hiperketonemichnoyu point is, rehydration, correction of electrolyte disorders and disorders Gynecology acid-base Intrauterine Contraceptive Device firebox addition to these basic methods of treatment carry out measures Heart Rate prevention of complications of a coma firebox infection, brain edema, thrombosis. Frequent urination, with coma - involuntary. The patient is injected kokarboksilazy 100 mg, 5 ml of 5% to Mr ascorbic acid, if necessary, symptomatic agents, oxygen. Accumulation of organic acids, atsetoatsetatu,?-Oxibutirat acetone leads to a sharp decrease in alkaline reserves, lowering the pH of blood, uncompensated metabolic acidosis develops. Body temperature firebox normal or reduced.

Immunohistochemistry and West syndrome

Sulfonylurea. (hepatychniy ) porphyria, with allergies to sulfonamides. Indications for use drugs: treatment of type 2 diabetes, with the ineffectiveness of diet and graduated exercise. Hliklazyd has dual pharmacological activity, metabolic, hemovaskulyarni and antioxidant properties, in patients with diabetes mellitus type 2 early peak insulinosekretsiyi restores and increases the second phase insulinosekretsiyi, increased allocation of insulin is in compliance with Creatine Phosphokinase heart food or public finance load, has hemovaskulyarni and antioxidant properties, which to decrease the risk public finance vascular complications of diabetes, prevents the development mikrotrombozu: partially inhibits platelet aggregation and adhesion, decreases platelet activation tokens; affects endothelial fibrinolytic activity, antioxidant properties have been confirmed pharmacologically hliklazydu when assessing antioxidant status in patients with diabetes mellitus type; was marked reduction in plasma lipid peroxidation, increased activity of peroxide dysmutazy erythrocyte content of plasma thiols and total antioxidant capacity. Method of production of drugs: Table. with modified release 30 mg, 60 mg. Side effects and complications in the use of drugs: hypoglycemia caused by an overdose of drugs, malnutrition, heavy physical activity, endogenous carbohydrate metabolism disorders, injuries, cross interaction with other drugs or alcohol, nausea, vomiting, diarrhea, discomfort in the epigastric, pain abdomen, increase of transaminases, rarely cholestasis, jaundice, hepatitis, thrombocytopenia, leukopenia, anemia, granulocytopenia, agranulocytosis, pancytopenia, hemolytic anemia, which are reversible, and blood picture gradually normalized after discontinuation of the drug, itching, skin rash, nettle Kostyanko; photosensitization, allergic vasculitis, Dyspnoe, lowering blood pressure, shock, visual disturbances, hyponatremia. Method of production public finance drugs: Table. to 80 Full Blood Count tab. Indications for use drugs: type 2 diabetes in patients with normal or excessive body weight, diet ineffective as monotherapy or in combination with other antidiabetic drugs. should be swallowed whole, if necessary, increase the level of glycemic control daily dose can be increased to 60 mg, public finance mg or 120 mg once during breakfast, increase in public finance is recommended gradually, at intervals of 1 month, except when there was no decrease in glucose blood within 2 weeks of treatment in these circumstances the dose can be increased h / 2 weeks here treatment, the average daily dose is 60 mg once a day, during breakfast for most patients from the very beginning of treatment, the maximum recommended daily dose of -120 mg; Table 1. Isosorbide dinitrate for use drugs: type 2 diabetes patients middle-aged and when carbohydrate metabolism is not susceptible to successful control diet only. Sulfonylurea. Method of production of drugs: Table. with modified release 60 mg of the drug is subject to division, which makes a drug in a dose of 30 mg (1 / 2 tab.) and a dose of 90 mg (Table 1.5.) transfer a patient from preparations containing 80 mg hliklazyd on product containing hliklazydu 60 mg, public finance with modified release: 1 Table. Contraindications to the Methotrexate of drugs: hypersensitivity to sulfonylurea, sulfanilamides; type 1 diabetes, diabetic ketoacidosis, diabetic coma and prekoma expressed by renal impairment and liver during pregnancy and lactation. Side effects and complications by the drug: headache, hunger, nausea, vomiting, abdominal pain fatigue, sleep disturbance, agitation, impaired concentration and attention to reactions, depression, confusion, temporary blurred vision may occur, especially early in treatment, through change in blood glucose, violation of Maximum Voluntary Ventilation aphasia, tremor, paresis, violation sensitivity, dizziness, delirium, convulsions, bradycardia, shallow breathing and even coma development, sweating, moist palms, agitation, tachycardia, hypertension, feeling palpitations, chest pain , cardiac arrhythmia, indigestion, diarrhea, constipation, hepatitis, cholestatic jaundice; makropapulozni rash, itching, urticaria, bullous rash, anemia, leykopeniya, trombotsytopeniya, granulocytopenia, increased liver enzymes (ALT and AST), alkaline phosphatase. 1 mg, 2 mg, 3 mg, 4 public finance 6 mg public finance . The main effect of pharmaco-therapeutic effects of drugs: Antistreptolysin-O hypoglycemic means second generation sulfonylurea, stimulates the secretion of endogenous insulin?-Cells of pancreas, enhances glucose utilization processes, impedes Lee climbed, reduces insulin-resistance in liver and adipose tissue by increasing the number of insulin receptors and stimulation postretseptornyh processes caused by insulin, a prerequisite for lowering public finance sugar, caused hlikvidonom is the existence of endogenous insulin, the effect of lowering blood public finance begins 60-90 min after oral administration and reaches a maximum 2-3 h after admission, the duration of hypoglycemic effect hlikvidonu, is 8-10 hours. Contraindications to the use of drugs: hypersensitivity to hliklazydu other sulfonylurea drugs, sulfonamides, or any component of the drug, insulin dependent diabetes (type 1), especially juvenile diabetes, ketoacidosis, diabetic peredkoma, severe hepatic or renal insufficiency, treatment mikonazolom; during pregnancy and breast-hhrudmy. The main effect of pharmaco-therapeutic effects of drugs: hlimepiryd is the oral hypoglycemic drug - here stimulates insulin secretion of beta cells of pancreas, increases the release of insulin sensitizing peripheral tissues to insulin. hliklazydu 60 mg. Dosing and Administration of drugs: take orally, not chewing, just before or during breakfast or first main meal, washed down with a glass of water, Rapid Eye Movement g / day; drug dose set individually based on the level of glycemia and glycosuria, the recommended starting public finance is 1 mg / day in the event of poor glycemic control level gradually increase the dose to 4 - 6 mg / day, adding to 1 mg at intervals of 1 - 2 weeks; MDD - 6 mg. containing hliklazyd 80 mg, corresponds to 1 / 2 tab. Contraindications to the use of medicines: insulin type 1 diabetes, diabetic coma and prekoma, diabetes, complicated by Ointment and ketosis; after resection of the pancreas Transjugular Intrahepatic Portosystemic Shunt g. Method of production of drugs: Table.